Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Baiyunshan Huacheng Pharmaceutical Co., Ltd. is a state-owned pharmaceutical manufacturer established in 1971 and based in Guangzhou, China. As a subsidiary of Guangzhou Pharmaceutical Holdings Limited (GPHL), the company specializes in the research, development, production, and sales of both traditional Chinese patent medicines and chemical pharmaceuticals. Its product portfolio features several well-known brands, including Guilubushen Pills (龟鹿补肾丸), Houerhuan Anti-inflammatory Tablets (猴耳环消炎片), Antiviral Oral Liquid (抗病毒口服液), and Qingnaofushen Liquid (清脑复神液). Operating from a modern GMP-certified facility in the Sino-Singapore Guangzhou Knowledge City, the company leverages strategic partnerships with academic institutions like Sun Yat-sen University to drive product optimization and secondary development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Baiyunshan Huacheng Pharmaceutical.